| 摘要 |
VEGF-binding molecules, preferably VEGF-binding immunoglobulin single variable domains like VHHs anddomain antibodies, pharmaceutical compositions containing same and their use in the treatment of diseases that are associated with VEGF- mediated effects on angiogenesis.Nucleic acids encoding VEGF-binding molecules, host cells and methods for preparing same. |
